Mosaic ImmunoEngineering receives $300k for preferred shares; stock moving to OTC Pink

Mosaic ImmunoEngineering Inc.

Redeemed remaining 910k Series A Preferred shares for $300k lump sum ($0.33/share), received June 22, 2023.
Board decided not to pay OTCQB semi-annual fees due June 30, 2023; stock will be quoted on OTC Pink from July 3, 2023.
Move to OTC Pink may adversely affect liquidity; company may not requalify for OTCQB.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Mosaic ImmunoEngineering Inc. amended Amendment No. 1 to the Original Redemption Agreement with Holocom, Inc. valued at $300,000 (effective 2023-06-21).

Action: amendment
Counterparty: Holocom, Inc.
Value: $300,000
Effective: 2023-06-21

Exact text from the filing

On June 21, 2023 (“Effective Date”), the Company and Holocom entered into Amendment No. 1 to the Original Redemption Agreement (“Amendment No. 1”) to redeem the remaining 910,000 shares of Series A Preferred Stock in exchange for proceeds to the Company of $300,000 due no later than three (3) business days from the Effective Date

View on SEC.gov

Browse all material agreements →

Mosaic ImmunoEngineering Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-004424

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.